Skip to content

Author

T. Bucci

We have 6 of 194 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Aspirin for primary prevention in patients with diabetes according to lipoprotein(a) levels: a real-world propensity-matched analysis

Aspirin may be considered for primary prevention in selected patients with diabetes mellitus (DM). Lipoprotein(a) [Lp(a)] is an independent cardiovascular risk factor linked to myocardial infarction and stroke and may promote thrombogenicity. Whether the association between aspirin use and cardiovascular outcomes...

M. Rossi, E. Tartaglia, A. Askarinejad et al. · 0 citations
Open access Oct 2026

Clinical phenotypes and echocardiographic profiles in young patients with atrial fibrillation: insights from european and asian cohorts

Atrial fibrillation (AF) in younger adults is a highly heterogeneous condition, encompassing a broad clinical spectrum and associated with markedly different cardiovascular outcomes. We aimed to identify distinct clinical–echocardiographic phenotypes of AF in patients aged <65 years and to evaluate their a...

A. Rigutini, T. Bucci, E. Tartaglia et al. · 0 citations
Open access Oct 2026

Circadian patterns of out-of-hospital cardiac arrest over 23 years in a large urban area of northern Italy

Out-of-hospital cardiac arrest (OHCA) remains a major public health challenge. Temporal patterns may have important implications for patient management and community strategies. To investigate the circadian distribution of OHCA occurrence, outcomes, and initial rhythm over 23 years in a large urban area of...

L. Gerra, D. Mei, T. Bucci et al. · 0 citations
Open access Oct 2026

Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis

Pulmonary vein isolation (PVI) is a well-established procedure for treating atrial fibrillation (AF); however, early recurrence of atrial tachyarrhythmias (ERAT) is common. Electrical cardioversion (ECV) is one treatment for ERAT, but optimal timing is unestablished. To evaluate the association between the...

L. Serio, A. Askarinejad, T. Bucci et al. · 0 citations
Open access Sep 2026

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network.

BACKGROUND AND AIM Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium-glucose cotransporter-2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with...

Leandra Serio, M. Rossi, A. Askarinejad et al. · 0 citations
Open access Aug 2026

Phenotypic clustering and ABC pathway adherence in patients with atrial fibrillation at high risk of bleeding and stroke: Insights from three global registries.

Three distinct phenotypic clusters were identified, each with heterogeneous clinical characteristics and outcomes, underscoring the need for more individualised, phenotype-informed management strategies in this complex patient population.

A. Askarinejad, T. Bucci, Enrico Tartaglia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.